By Delilah Alvarado Published October 12, 2026 In a significant development for the immunology landscape, biotechnology firm...
Ali Ikhwan
In a compelling shift in the understanding of neurodegenerative disease, researchers at the Broad Institute of MIT...
By Douglas Feil, Chief Program Officer, National Breast Cancer Foundation (NBCF) In recent years, glucagon-like peptide-1 (GLP-1)...
In the landscape of modern drug discovery, the traditional approach to toxicology and pathology has long been...
In a move that reverberated through the corridors of international diplomacy and global health policy, the United...
In a landmark decision that promises to reshape the treatment landscape for one of the most aggressive...
The landscape of preclinical drug discovery is undergoing a profound metamorphosis. For decades, the standard for toxicology...
AMMAN, JORDAN — The World Health Organization (WHO) Director-General, Dr. Tedros Adhanom Ghebreyesus, has concluded the first...
By Editorial Staff, Health & Science Division Disclaimer: The information provided in this article is for educational...
In a landmark achievement for genomic medicine, researchers at Newcastle University and The Newcastle upon Tyne Hospitals...
